Phillip Frost
10.03.2010
Eli Hurvitz is standing down from the chairmanship of Israel's Teva Pharmaceutical Industries , ending a 30-year term at the company during which he led it to become the world's biggest generic drugmaker.
Vice Chairman Phillip Frost will replace Hurvitz, who had taken a three-week medical leave of absence in mid-February to recuperate from treatment for an undisclosed illness and was due to return this week.
In a statement on Tuesday, Teva said Hurvitz had indicated in a letter he wished to be released from his duties in order to focus on making a full recovery.
more